Such a specific upregulation of ALDH6A1 in PCa tissues may be potentially explained by its dependence on androgen signaling and by the importance of the AR in the progression of PCa since the treatment of LNCaP cells with antiandrogen bicalutamide decreased the ALDH6A1 protein level [144]. The gene discussed is AR; the disease is posterior cortical atrophy.